Barnaby Pickering
Reporter, Medtech Insight
Graduating in 2020 with a Master’s degree in biomedical engineering from University College London, Barnaby is passionate about all things medtech. In his first role as a journalist, Barnaby will focus on R&D and commercial stories in medtech, and writing about emerging technologies such as digital health, artificial intelligence, machine learning, deep-brain implants, and nanoscale applications of medtech. Alongside this, Barnaby is looking forward to taking deeper dives into start-ups, device market analysis, and company financial data, to create informed, useful, and engaging content.
Barnaby lives in in rural Wiltshire, UK and is a keen reader, cyclist, and hobbyist jeweler.
Latest From Barnaby Pickering
Babson Diagnostics Plans To Deliver What Theranos Could Not
Babson recently raised $31m to accelerate commercialization of its blood testing “ecosystem,” developed with help from Siemens Healthineers and Becton Dickinson.
First Test That Predicts Severe Outcomes In COVID-19 Patients Receives CE Mark
MeMed’s test measures immune system response to assess a patient’s COVID-19 trajectory.
Device Week, 23 July – Digital Health Deals; SPACS; Novel Approach To Liquid Biopsy
In this edition of Device Week, Medtech Insight’s Marion Webb reviews the huge number of digital health investments announced in 2021, including numerous SPAC deals. UK-based reporter Barnaby Pickering talks about Angle, a British liquid diagnostics company that has developed a novel approach to liquid diagnostics.
Digital Health Roundup, June 2021: Winners In Record-Breaking H1 Digital Health Funding; ADA 2021; Telehealth Update
In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from June.
Merck Jumps On Neurostim Technology, Signing Agreements With Start-Ups
The biotech giant signed a commercial agreement with bioelectronics company Innervia, and the two will work collaboratively on vagus nerve stimulating technologies.
Foundation Medicine Obtains FDA Approval For Non Small Cell Lung Cancer Companion Diagnostic
Foundation Medicine and Novartis’ commercial partnership has achieved another success as Foudation’s Liquid CDx is approved.